Lippia alba (Bushy Matgrass)
Lippia alba is an Amazonian herb containing carvone, limonene, and citral as primary bioactive compounds. It demonstrates antigenotoxic effects through DNA protection mechanisms and antimicrobial activity via essential oil components.

Origin & History
Lippia alba, known as bushy matgrass, is an aromatic medicinal plant native to South America, particularly Colombia and southern Brazil, belonging to the Verbenaceae family. The essential oil is obtained from leaves and stems via hydrodistillation for 3 hours after boiling, yielding 0.311-0.363% (w/w) extract with volatile monoterpenes and sesquiterpenes that vary by chemotype.
Historical & Cultural Context
Lippia alba has been used in South American folk medicine as an aromatic and medicinal plant with reported physiotherapeutic, antimicrobial, antioxidant, and antifungal properties. The plant has applications in both pharmaceutical and chemical industries, though specific traditional systems and historical duration of use are not detailed.
Health Benefits
• Antigenotoxic properties - In vitro studies demonstrate protection against bleomycin-induced DNA damage (preliminary evidence) • Antimicrobial activity - Traditional use supported by essential oil composition but lacks clinical validation • Antioxidant effects - Traditional applications suggest benefits, though human studies are absent • Antifungal properties - Historically used in folk medicine, no clinical trials available • Aromatic therapeutic applications - Used in pharmaceutical and chemical industries for physiotherapeutic purposes (traditional evidence only)
How It Works
Lippia alba's antigenotoxic effects occur through protection of DNA against oxidative damage, particularly bleomycin-induced strand breaks. The essential oil components carvone, limonene, and citral exhibit antimicrobial activity by disrupting bacterial cell membrane integrity and inhibiting microbial enzyme systems.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses on Lippia alba were identified in the available research. Current studies focus exclusively on chemical composition analysis, in vitro antigenotoxic properties, and plant responses to environmental stress.
Clinical Summary
Current evidence for Lippia alba consists primarily of in vitro studies demonstrating protection against bleomycin-induced DNA damage. Antimicrobial studies have focused on essential oil composition analysis rather than controlled clinical trials. Traditional use reports exist for antioxidant and digestive applications, but these lack rigorous clinical validation. No human clinical trials have been conducted to establish therapeutic efficacy or optimal dosing protocols.
Nutritional Profile
{"macronutrients": {"protein": "Not significant", "fiber": "Not significant"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts"}, "minerals": {"Calcium": "Trace amounts", "Magnesium": "Trace amounts"}}, "bioactive_compounds": {"essential_oils": {"citral": "0.5-1.0% of leaf weight", "limonene": "0.2-0.5% of leaf weight", "myrcene": "0.1-0.3% of leaf weight"}, "flavonoids": {"quercetin": "Trace amounts"}}, "bioavailability_notes": "Bioactive compounds such as essential oils are better absorbed when consumed with fats. Flavonoids like quercetin have low bioavailability but can be enhanced with the presence of fats or other enhancing agents like piperine."}
Preparation & Dosage
No clinically studied dosage ranges are available due to absence of human trials. Essential oil extraction yields range from 0.311% to 0.363% (w/w) from leaves via hydrodistillation. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Lemon balm, Peppermint, Chamomile, Ginger, Turmeric
Safety & Interactions
Safety data for Lippia alba supplementation is limited due to lack of clinical studies. Essential oil components may cause skin irritation or allergic reactions in sensitive individuals. Potential interactions with medications metabolized by liver enzymes are theoretically possible due to terpene content. Pregnancy and breastfeeding safety has not been established, so use should be avoided during these periods.